ABC: Heart Failure & Cardiomyopathy最新文献

筛选
英文 中文
Heart Failure Due to Cardiac Transthyretin Amyloidosis 心脏转甲状腺素淀粉样变引起的心力衰竭
ABC: Heart Failure & Cardiomyopathy Pub Date : 1900-01-01 DOI: 10.36660/abchf.20210024
Humberto Butzke da Motta, Guilherme Oliveira Magalhães Costa, A. Biolo
{"title":"Heart Failure Due to Cardiac Transthyretin Amyloidosis","authors":"Humberto Butzke da Motta, Guilherme Oliveira Magalhães Costa, A. Biolo","doi":"10.36660/abchf.20210024","DOIUrl":"https://doi.org/10.36660/abchf.20210024","url":null,"abstract":"","PeriodicalId":277175,"journal":{"name":"ABC: Heart Failure & Cardiomyopathy","volume":"298 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132185577","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What is the Importance of Clinical Clues, and How can we Avoid Mistakes in Following Them? 临床线索的重要性及如何避免错误?
ABC: Heart Failure & Cardiomyopathy Pub Date : 1900-01-01 DOI: 10.36660/abchf.20210020
S. Rassi, D. Rassi, A. F. Freitas
{"title":"What is the Importance of Clinical Clues, and How can we Avoid Mistakes in Following Them?","authors":"S. Rassi, D. Rassi, A. F. Freitas","doi":"10.36660/abchf.20210020","DOIUrl":"https://doi.org/10.36660/abchf.20210020","url":null,"abstract":"","PeriodicalId":277175,"journal":{"name":"ABC: Heart Failure & Cardiomyopathy","volume":"3 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128921714","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Importance of the DEIC/GEMIC/SBC 2021 Position Statement on Diagnosis and Treatment of Cardiac Amyloidosis to Clinical Practice DEIC/GEMIC/SBC 2021关于心脏淀粉样变性诊断和治疗的立场声明对临床实践的重要性
ABC: Heart Failure & Cardiomyopathy Pub Date : 1900-01-01 DOI: 10.36660/abchf.20210021
M. Simões, F. Fernandes
{"title":"The Importance of the DEIC/GEMIC/SBC 2021 Position Statement on Diagnosis and Treatment of Cardiac Amyloidosis to Clinical Practice","authors":"M. Simões, F. Fernandes","doi":"10.36660/abchf.20210021","DOIUrl":"https://doi.org/10.36660/abchf.20210021","url":null,"abstract":"The latest edition of Arquivos Brasileiros de Cardiologia has brought us the publication of the Position Statement on Diagnosis and Treatment of Cardiac Amyloidosis by the DEIC/ GEMIC/SBC. This document was the result of the collaborative efforts of many experts in the area, exponents of cardiology in Brazil, but it also included other specialists, such as neurologists, hematologists and nuclear physicians. The need to bring together this group of collaborators reflects a fundamental aspect of amyloidosis, namely, a complex and multifaceted disease that affects multiple organs and requires the assistance of several specialties for comprehensive management. This was, in fact, a positive aspect of the document: its scope and multidisciplinary character. It is here appropriate to state the reasons that led the DEIC/GEMIC/SBC to produce this document, fulfilling the mission of producing documents that contribute to updating science and medical education, offering the signposts that are necessary to guide the practice of cardiology based on scientific evidence. The sense of urgency for this action was the clear perception of the recent and profound reformulation of concepts regarding cardiac amyloidosis (CA), including evidence that it is a more prevalent disease than previously imagined, the significant advance in imaging methods that has made non-invasive diagnosis possible, and the emergence of new specific treatments that can change the natural history of the disease (Figure 1).","PeriodicalId":277175,"journal":{"name":"ABC: Heart Failure & Cardiomyopathy","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128536965","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
First Combined Heart-Liver Transplant in Amyloidosis Due to Transthyretin Mutation in Brazil: Impact of the Liver on Reducing anti-HLA Antibodies 巴西首例因转甲状腺素突变引起的淀粉样变性的心脏-肝脏联合移植:肝脏对降低hla抗体的影响
ABC: Heart Failure & Cardiomyopathy Pub Date : 1900-01-01 DOI: 10.36660/abchf.20210029
S. Mangini, Bianca de Cássia Sabbion, R. Poffo, Sérgio Paiva Meira, M. Almeida, F. Bacal
{"title":"First Combined Heart-Liver Transplant in Amyloidosis Due to Transthyretin Mutation in Brazil: Impact of the Liver on Reducing anti-HLA Antibodies","authors":"S. Mangini, Bianca de Cássia Sabbion, R. Poffo, Sérgio Paiva Meira, M. Almeida, F. Bacal","doi":"10.36660/abchf.20210029","DOIUrl":"https://doi.org/10.36660/abchf.20210029","url":null,"abstract":"","PeriodicalId":277175,"journal":{"name":"ABC: Heart Failure & Cardiomyopathy","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124341303","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Disease Modifying Therapies for Transthyretin Amyloid Cardiomyopathy 转甲状腺素淀粉样蛋白心肌病的疾病修饰疗法
ABC: Heart Failure & Cardiomyopathy Pub Date : 1900-01-01 DOI: 10.36660/abchf.20210034
A. Macedo, F. Fernandes, R. Lopes
{"title":"Disease Modifying Therapies for Transthyretin Amyloid Cardiomyopathy","authors":"A. Macedo, F. Fernandes, R. Lopes","doi":"10.36660/abchf.20210034","DOIUrl":"https://doi.org/10.36660/abchf.20210034","url":null,"abstract":"","PeriodicalId":277175,"journal":{"name":"ABC: Heart Failure & Cardiomyopathy","volume":"24 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125943506","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信